Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aya Gold & Silver Inc. stock logo
AYA
Aya Gold & Silver
$28.19
-7.2%
$25.50
$15.84
$30.67
$4.38BN/A1.35 million shs1.28 million shs
Carlyle Group Inc. stock logo
CG
Carlyle Group
$39.92
-0.8%
$46.18
$39.16
$67.46
$14.34B1.843.18 million shs2.60 million shs
Elemental Royalty Corp stock logo
ELE
Elemental Royalty
$20.43
-4.7%
$19.45
$12.58
$26.96
$1.38BN/A412,281 shs351,788 shs
10x Genomics stock logo
TXG
10x Genomics
$75.62
-6.3%
$59.11
$11.16
$82.68
$10.51B2.082.54 million shs3.47 million shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aya Gold & Silver Inc. stock logo
AYA
Aya Gold & Silver
-7.21%+5.38%+6.06%+54.21%+2,818,999,900.00%
Carlyle Group Inc. stock logo
CG
Carlyle Group
-0.77%-0.22%-18.76%-4.73%-40.60%
Elemental Royalty Corp stock logo
ELE
Elemental Royalty
-4.67%+2.05%-9.28%+34.76%+2,042,999,900.00%
10x Genomics stock logo
TXG
10x Genomics
-6.29%+4.05%+18.53%+111.64%+505.44%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aya Gold & Silver Inc. stock logo
AYA
Aya Gold & Silver
$28.19
-7.2%
$25.50
$15.84
$30.67
$4.38BN/A1.35 million shs1.28 million shs
Carlyle Group Inc. stock logo
CG
Carlyle Group
$39.92
-0.8%
$46.18
$39.16
$67.46
$14.34B1.843.18 million shs2.60 million shs
Elemental Royalty Corp stock logo
ELE
Elemental Royalty
$20.43
-4.7%
$19.45
$12.58
$26.96
$1.38BN/A412,281 shs351,788 shs
10x Genomics stock logo
TXG
10x Genomics
$75.62
-6.3%
$59.11
$11.16
$82.68
$10.51B2.082.54 million shs3.47 million shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aya Gold & Silver Inc. stock logo
AYA
Aya Gold & Silver
-7.21%+5.38%+6.06%+54.21%+2,818,999,900.00%
Carlyle Group Inc. stock logo
CG
Carlyle Group
-0.77%-0.22%-18.76%-4.73%-40.60%
Elemental Royalty Corp stock logo
ELE
Elemental Royalty
-4.67%+2.05%-9.28%+34.76%+2,042,999,900.00%
10x Genomics stock logo
TXG
10x Genomics
-6.29%+4.05%+18.53%+111.64%+505.44%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aya Gold & Silver Inc. stock logo
AYA
Aya Gold & Silver
3.25
BuyN/AN/A
Carlyle Group Inc. stock logo
CG
Carlyle Group
2.40
Hold$59.3148.57% Upside
Elemental Royalty Corp stock logo
ELE
Elemental Royalty
2.33
Hold$31.0051.74% Upside
10x Genomics stock logo
TXG
10x Genomics
2.24
Hold$44.00-41.81% Downside

Current Analyst Ratings Breakdown

Latest ELE, TXG, CG, and AYA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/22/2026
Elemental Royalty Corp stock logo
ELE
Elemental Royalty
Lower Price TargetBuy$33.00 ➝ $31.00
9/21/2026
10x Genomics stock logo
TXG
10x Genomics
Reiterated RatingSell (D-)
9/9/2026
10x Genomics stock logo
TXG
10x Genomics
Initiated CoverageNeutral$20.00 ➝ $68.00
9/1/2026
10x Genomics stock logo
TXG
10x Genomics
Initiated CoverageSector Perform$70.00
9/1/2026
10x Genomics stock logo
TXG
10x Genomics
Initiated CoverageSector Perform$70.00
8/31/2026
Aya Gold & Silver Inc. stock logo
AYA
Aya Gold & Silver
Reiterated RatingHold (C+)
8/12/2026
Elemental Royalty Corp stock logo
ELE
Elemental Royalty
UpgradeSell (D+)Hold (C)
8/12/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetOverweight$50.00 ➝ $65.00
8/12/2026
Elemental Royalty Corp stock logo
ELE
Elemental Royalty
Boost Price TargetBuy$32.50 ➝ $33.00
8/11/2026
Carlyle Group Inc. stock logo
CG
Carlyle Group
UpgradeHold (C-)Hold (C)
8/10/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetNeutral$42.00 ➝ $47.00
(Data available from 9/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aya Gold & Silver Inc. stock logo
AYA
Aya Gold & Silver
$202.10M20.09N/AN/AN/A
Carlyle Group Inc. stock logo
CG
Carlyle Group
$4.78B2.98$5.18 per share7.70$19.58 per share2.04
Elemental Royalty Corp stock logo
ELE
Elemental Royalty
$43.64M30.11$0.27 per share75.44$12.23 per share1.67
10x Genomics stock logo
TXG
10x Genomics
$642.82M15.33N/AN/A$6.24 per share12.12
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aya Gold & Silver Inc. stock logo
AYA
Aya Gold & Silver
$45.56M$0.5650.3425.40N/A32.92%25.49%17.70%N/A
Carlyle Group Inc. stock logo
CG
Carlyle Group
$808.70M$0.9641.587.721.2610.08%22.52%5.62%11/6/2026 (Estimated)
Elemental Royalty Corp stock logo
ELE
Elemental Royalty
$1.77M$0.08255.3847.51N/A4.01%0.53%0.46%N/A
10x Genomics stock logo
TXG
10x Genomics
-$43.54M-$0.59N/AN/AN/A-12.18%-9.33%-7.30%11/5/2026 (Estimated)

Latest ELE, TXG, CG, and AYA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
Aya Gold & Silver Inc. stock logo
AYA
Aya Gold & Silver
$0.36$0.23-$0.13$0.23N/AN/A
8/11/2026Q2 2026
Elemental Royalty Corp stock logo
ELE
Elemental Royalty
$0.13$0.06-$0.07$0.05N/A$23.79 million
8/6/2026Q2 2026
10x Genomics stock logo
TXG
10x Genomics
-$0.2431-$0.14+$0.1031-$0.14$146.67 million$151.04 million
8/4/2026Q2 2026
Carlyle Group Inc. stock logo
CG
Carlyle Group
$0.9110$1.07+$0.1590$0.37$923.51 million$1.11 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Aya Gold & Silver Inc. stock logo
AYA
Aya Gold & Silver
N/AN/AN/AN/AN/A
Carlyle Group Inc. stock logo
CG
Carlyle Group
$1.403.51%+6.96%145.83%4 Years
Elemental Royalty Corp stock logo
ELE
Elemental Royalty
$0.120.59%N/A150.00%N/A
10x Genomics stock logo
TXG
10x Genomics
N/AN/AN/AN/AN/A

Latest ELE, TXG, CG, and AYA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/17/2026
Elemental Royalty Corp stock logo
ELE
Elemental Royalty
quarterly$0.030.56%9/30/20269/30/202610/15/2026
7/24/2026
Carlyle Group Inc. stock logo
CG
Carlyle Group
quarterly$0.352.88%8/17/20268/17/20268/26/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aya Gold & Silver Inc. stock logo
AYA
Aya Gold & Silver
0.11
2.02
1.70
Carlyle Group Inc. stock logo
CG
Carlyle Group
1.91
2.35
2.35
Elemental Royalty Corp stock logo
ELE
Elemental Royalty
N/A
5.48
5.48
10x Genomics stock logo
TXG
10x Genomics
N/A
5.69
5.25

Institutional Ownership

CompanyInstitutional Ownership
Aya Gold & Silver Inc. stock logo
AYA
Aya Gold & Silver
N/A
Carlyle Group Inc. stock logo
CG
Carlyle Group
55.88%
Elemental Royalty Corp stock logo
ELE
Elemental Royalty
N/A
10x Genomics stock logo
TXG
10x Genomics
84.68%

Insider Ownership

CompanyInsider Ownership
Aya Gold & Silver Inc. stock logo
AYA
Aya Gold & Silver
N/A
Carlyle Group Inc. stock logo
CG
Carlyle Group
25.40%
Elemental Royalty Corp stock logo
ELE
Elemental Royalty
N/A
10x Genomics stock logo
TXG
10x Genomics
8.84%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aya Gold & Silver Inc. stock logo
AYA
Aya Gold & Silver
810144.06 millionN/AN/A
Carlyle Group Inc. stock logo
CG
Carlyle Group
2,500356.33 million265.82 millionOptionable
Elemental Royalty Corp stock logo
ELE
Elemental Royalty
3964.31 millionN/AN/A
10x Genomics stock logo
TXG
10x Genomics
1,178130.29 million118.77 millionOptionable

Recent News About These Companies

3 Analysts, 3 Trades to Make Today
Beyond Meta, Cathie Wood’s ARKG Loads Up On These 4 Biotech Names
10x Genomics (NASDAQ:TXG) Given Consensus Rating of "Hold" by Brokerages
10x Genomics Inc Class A
UBS Sticks to Its Hold Rating for 10x Genomics (TXG)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Aya Gold & Silver stock logo

Aya Gold & Silver NASDAQ:AYA

$28.19 -2.19 (-7.21%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$28.34 +0.15 (+0.53%)
As of 09/23/2026 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aya Gold & Silver Inc., together with its subsidiaries, engages in the exploration, evaluation and development of precious metals projects principally in Morocco. The company primarily explores for gold and silver deposits. Its flagship project holds Zgounder property. Aya Gold & Silver Inc. is based in Mount Royal, Canada.

Carlyle Group stock logo

Carlyle Group NASDAQ:CG

$39.92 -0.31 (-0.77%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$40.01 +0.09 (+0.23%)
As of 09/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in management-led/ Leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and venture and growth capital financings, seed/startup, early venture, emerging growth, turnaround, mid venture, late venture, PIPES. The firm invests across four segments which include Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions. The firm typically invests in industrial, agribusiness, ecological sector, fintech, airports, parking, Plastics, Rubber, diversified natural resources, minerals, farming, aerospace, defense, automotive, consumer, retail, industrial, infrastructure, energy, power, healthcare, software, software enabled services, semiconductors, communications infrastructure, financial technology, utilities, gaming, systems and related supply chain, electronic systems, systems, oil and gas, processing facilities, power generation assets, technology, systems, real estate, financial services, transportation, business services, telecommunications, media, and logistics sectors. Within the industrial sector, the firm invests in manufacturing, building products, packaging, chemicals, metals and mining, forestry and paper products, and industrial consumables and services. In consumer and retail sectors, it invests in food and beverage, retail, restaurants, consumer products, domestic consumption, consumer services, personal care products, direct marketing, and education. Within aerospace, defense, business services, and government services sectors, it seeks to invest in defense electronics, manufacturing and services, government contracting and services, information technology, distribution companies. In telecommunication and media sectors, it invests in cable TV, directories, publishing, entertainment and content delivery services, wireless infrastructure/services, fixed line networks, satellite services, broadband and Internet, and infrastructure. Within real estate, the firm invests in office, hotel, industrial, retail, for sale residential, student housing, hospitality, multifamily residential, homebuilding and building products, and senior living sectors. The firm seeks to make investments in growing business including those with overleveraged balance sheets. The firm seeks to hold its investments for four to six years. In the healthcare sector, it invests in healthcare services, outsourcing services, companies running clinical trials for pharmaceutical companies, managed care, pharmaceuticals, pharmaceutical related services, healthcare IT, medical, products, and devices. It seeks to invest in companies based in Sub-Saharan focusing on Ghana, Kenya, Mozambique, Botswana, Nigeria, Uganda, West Africa, North Africa and South Africa focusing on Tanzania and Zambia; Asia focusing on Pakistan, India, South East Asia, Indonesia, Philippines, Vietnam, Korea, and Japan; Australia; New Zealand; Europe focusing on France, Italy, Denmark, United Kingdom, Germany, Austria, Belgium, Finland, Iceland, Ireland, Netherlands, Norway, Portugal, Spain, Benelux , Sweden, Switzerland, Hungary, Poland, and Russia; Middle East focusing on Bahrain, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Turkey, and UAE; North America focusing on United States which further invest in Southeastern United States, Texas, Boston, San Francisco Bay Area and Pacific Northwest; Asia Pacific; Soviet Union, Central-Eastern Europe, and Israel; Nordic region; and South America focusing on Mexico, Argentina, Brazil, Chile, and Peru. The firm seeks to invest in food, financial, and healthcare industries in Western China. In the real estate sector, the firm seeks to invest in various locations across Europe focusing on France and Central Europe, United States, Asia focusing on China, and Latin America. It typically invests between $1 million and $50 million for venture investments and between $50 million and $2 billion for buyouts in companies with enterprise value of between $31.57 million and $1000 million and sales value of $10 million and $500 million. It seeks to invest in companies with market capitalization greater than $50 million and EBITDA between $5 million to $25 million. It prefers to take a majority or a minority stake. While investing in Japan, it does not invest in companies with more than 1,000 employees and prefers companies' worth between $100 million and $150 million. The firm originates, structures, and acts as lead equity investor in the transactions. The Carlyle Group Inc. was founded in 1987 and is based in Washington, District of Columbia with additional offices in 21 countries across 5 continents (North America, South America, Asia, Australia and Europe).

Elemental Royalty stock logo

Elemental Royalty NASDAQ:ELE

$20.43 -1.00 (-4.67%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$20.45 +0.02 (+0.12%)
As of 09/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Elemental Royalty Corporation engages in the acquisition and generation of precious metal royalties. The company holds royalties in gold, silver, and copper projects. It operates in North America; South America; Australia; Africa; and internationally. The company was formerly known as Elemental Altus Royalties Corp. and changed its name to Elemental Royalty Corporation in November 2025. The company is headquartered in Vancouver, Canada.

10x Genomics stock logo

10x Genomics NASDAQ:TXG

$75.62 -5.08 (-6.29%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$75.58 -0.04 (-0.05%)
As of 09/23/2026 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.